Page 3 - Nasdaq Rlmd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rlmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rlmd Today - Breaking & Trending Today

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the four brokerages that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average […] ....

Jpmorgan Chase Co , York Mellon Corp , Advisor Group Holdings Inc , Relmada Therapeutics Company Profile , Citigroup Inc , Proshare Advisors , Relmada Therapeutics Inc , Relmada Therapeutics , Get Free Report , Marketbeat Ratings , Group Holdings , Share Advisors , New York Mellon Corp , Get Free , Relmada Therapeutics Daily , Nasdaq Rlmd ,

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Given Average Recommendation of "Hold" by Brokerages

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) has received a consensus rating of “Hold” from the six analysts that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokers […] ....

York Mellon Corp , Relmada Therapeutics Company Profile , Advisor Group Holdings Inc , Citigroup Inc , Relmada Therapeutics Inc , Proshare Advisors , Jpmorgan Chase Co , Relmada Therapeutics , Get Free Report , Group Holdings , Share Advisors , New York Mellon Corp , Get Free , Relmada Therapeutics Daily , Nasdaq Rlmd ,

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Short Interest Update

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) was the recipient of a significant decline in short interest in August. As of August 15th, there was short interest totalling 689,800 shares, a decline of 18.8% from the July 31st total of 849,900 shares. Based on an average daily trading volume, of 169,700 shares, the short-interest […] ....

United States , Capital Partners , Advisorshares Investments , Chicago Partners Investment Group , Guild Investment Management Inc , Relmada Therapeutics Inc , Relmada Therapeutics Company Profile , Parsons Capital Management Inc , Relmada Therapeutics , Get Free Report , Partners Investment Group , Shares Investments , Investment Management , Parsons Capital Management , Capital Management , Relmada Therapeutics Daily , Nasdaq Rlmd ,

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month […] ....

United States , Cedric Ogorman , Advisorshares Investments , Parsons Capital Management Inc , Capital Partners , Relmada Therapeutics Inc , Chicago Partners Investment Group , Guild Investment Management Inc , Relmada Therapeutics , Get Free Report , Marketbeat Ratings , Cedrico Gorman , Partners Investment Group , Shares Investments , Investment Management , Parsons Capital Management , Capital Management , Therapeutics Trading Down , Get Free , Relmada Therapeutics Daily , Nasdaq Rlmd ,

Tiedemann Advisors LLC Acquires 10,000 Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD)

Tiedemann Advisors LLC boosted its holdings in Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Rating) by 97.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,215 shares of the company’s stock after buying an additional 10,000 shares during the quarter. […] ....

Los Angeles , United States , Relmada Therapeutics Company Profile , Relmada Therapeutics Inc , Los Angeles Capital Management , Asset Group Inc , Advisory Research Inc , Exchange Commission , Tiedemann Advisors , Exchange Traded Concepts , Relmada Therapeutics , Get Rating , Angeles Capital Management , Traded Concepts , Asset Group , Advisory Research , Visit Holdingschannel , Relmada Therapeutics Daily , Nasdaq Rlmd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,